JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 114 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $159,000 | -72.3% | 52,462 | -23.7% | 0.00% | – |
Q4 2021 | $574,000 | +124.2% | 68,776 | +100.0% | 0.00% | – |
Q3 2021 | $256,000 | -52.3% | 34,388 | -56.4% | 0.00% | – |
Q2 2021 | $537,000 | +219.6% | 78,923 | +223.9% | 0.00% | – |
Q2 2020 | $168,000 | -43.6% | 24,367 | -28.5% | 0.00% | – |
Q4 2019 | $298,000 | -46.5% | 34,068 | -79.6% | 0.00% | -100.0% |
Q3 2019 | $557,000 | -15.6% | 167,038 | +25.2% | 0.00% | 0.0% |
Q2 2019 | $660,000 | -38.8% | 133,443 | -23.2% | 0.00% | 0.0% |
Q1 2019 | $1,078,000 | +241.1% | 173,808 | +85.3% | 0.00% | – |
Q4 2018 | $316,000 | -29.8% | 93,776 | +35.5% | 0.00% | -100.0% |
Q3 2018 | $450,000 | -34.8% | 69,204 | +124.1% | 0.00% | 0.0% |
Q1 2018 | $690,000 | +154.6% | 30,879 | +59.8% | 0.00% | – |
Q2 2017 | $271,000 | -39.1% | 19,323 | -4.5% | 0.00% | -100.0% |
Q1 2017 | $445,000 | – | 20,240 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP II, LLC | 572,829 | $1,340,000 | 100.00% |
TRV GP III, LLC | 1,148,780 | $2,688,000 | 1.17% |
COWEN AND COMPANY, LLC | 3,647,430 | $8,535,000 | 0.82% |
Octagon Capital Advisors LP | 1,400,000 | $3,276,000 | 0.56% |
Deep Track Capital, LP | 4,259,653 | $9,968,000 | 0.46% |
PFM Health Sciences, LP | 4,094,488 | $9,581,000 | 0.35% |
RTW INVESTMENTS, LP | 5,106,341 | $11,949,000 | 0.28% |
Omega Fund Management, LLC | 275,513 | $645,000 | 0.24% |
Monarch Partners Asset Management LLC | 228,370 | $534,000 | 0.16% |
Orbimed Advisors | 2,928,900 | $6,854,000 | 0.13% |